Open AccessAssociation of PDGFRB Mutations With Pediatric Myofibroma and Myofibromatosis
Author(s) -
Guillaume Dachy,
Ronald R. de Krijger,
S. Fraitag,
Ivan Théate,
Bénédicte Brichard,
Suma B. Hoffman,
Louis Libbrecht,
Florence A. Arts,
Pascal Brouillard,
Miikka Vikkula,
Nisha Limaye,
JeanBaptiste Demoulin
Publication year - 2019
Publication title -
jama dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.128
H-Index - 166
eISSN - 2168-6084
pISSN - 2168-6068
DOI - 10.1001/jamadermatol.2019.0114
Subject(s) - pdgfrb , medicine , imatinib , mutation , tyrosine kinase , oncology , pathology , cancer research , genetics , biology , receptor , gene , myeloid leukemia
Myofibroma is the most frequent fibrous tumor in children. Multicentric myofibroma (referred to as infantile myofibromatosis) is a life-threatening disease.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom